Every 8-K that NCS Multistage Holdings, Inc. (NCSM) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow NCSM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NCSM filings page.
NCS Multistage Holdings, Inc. (symbol: NCSM) is the issuer of record for a Form 8-K filing submitted to the SEC.
NCS Multistage Holdings, Inc. (symbol: NCSM) is the issuer of record for a Form 8-K filing submitted to the SEC.
NCS Multistage Holdings, Inc. reported second‑quarter 2026 revenue of $38.4 million, up from $36.5 million a year earlier, driven by strong U.S. growth at Repeat Precision and tracer diagnostics, partially offset by weaker Canadian activity and lower international tracer diagnostics work.
Gross profit was $13.1 million with a 34% margin, consistent with last year, but higher selling, general and administrative expenses of $18.0 million, including professional fees for the pending Weatherford transaction and costs from the ResMetrics acquisition, contributed to a net loss attributable to NCS of $4.6 million, or $1.71 per share, versus net income of $0.9 million, or $0.34 per diluted share, in 2025. Adjusted EBITDA declined to $1.9 million with a 5% margin.
For the first six months of 2026, revenue was $84.0 million and free cash flow less distributions to non‑controlling interest was negative $1.6 million. Liquidity included $31.3 million of cash, $7.5 million of finance‑lease indebtedness and $14.5 million of unused ABL capacity. The agreed merger with Weatherford is expected to close in the second half of 2026 and has already received written‑consent approval from a holder of more than 50% of NCS’s outstanding common stock.
NCS Multistage Holdings, Inc. agreed to be acquired by Weatherford International plc, with NCS becoming a wholly owned subsidiary after a merger with a Weatherford subsidiary, subject to customary regulatory and closing conditions and targeted for completion in the second half of 2026.
NCS stockholders can elect either 0.5537 Weatherford ordinary shares per NCS share or a mixed package of cash equal to 0.1371 Weatherford shares plus 0.2392 Weatherford shares, with unelected shares defaulting to the stock-only option. On a blended basis, Weatherford expects this to equal 0.463 Weatherford shares per NCS share, with up to 19.99% of the equity consideration payable in cash. Weatherford expects at least $15 million of annual cost synergies within 18 months of closing.
NCS Multistage Holdings, Inc. reported results from its 2026 Annual Meeting of Stockholders. Total votes eligible were 2,624,523, and 2,228,707 votes were cast, representing approximately 84.9% of the eligible votes.
Stockholders elected Class III directors John Deane and W. Matt Ralls to serve until the 2029 Annual Meeting. Deane received 1,800,311 votes for and 142,468 withheld, while Ralls received 1,858,268 votes for and 84,511 withheld, with 285,928 broker non-votes for each nominee.
Stockholders also ratified the appointment of Grant Thornton LLP as independent registered public accounting firm for the year ending December 31, 2026, with 2,226,925 votes for, 849 against, and 933 abstentions. On an advisory basis, compensation of the named executive officers was approved with 1,938,033 votes for, 3,111 against, 1,635 abstentions, and 285,928 broker non-votes.
NCS Multistage Holdings, Inc. reported softer first quarter 2026 results, moving to a small net loss despite positive cash generation. Total revenues were $45.6 million for the quarter ended March 31, 2026, down from $50.0 million a year earlier, mainly from weaker Canadian and international activity.
Gross profit was $17.4 million, a 38% gross margin, compared with $21.1 million and a 42% margin in the prior-year quarter. Net loss attributable to NCS was $(0.4) million, or $(0.14) per share, versus net income of $4.1 million, or $1.51 per diluted share. Adjusted EBITDA declined to $5.6 million, a 12% margin, from $8.2 million and a 16% margin.
The company emphasized cost control and cash generation, with SG&A reduced to $15.7 million and operating activities providing $1.3 million of cash versus a use in the prior year. Free cash flow was $0.7 million. NCS ended the quarter with $34.5 million in cash, $7.2 million of finance-lease debt, working capital of $95.1 million and an undrawn ABL borrowing base of $18.5 million, supporting its view of a strong balance sheet and capacity to fund growth initiatives.
NCS Multistage Holdings, Inc. reported significantly stronger results for the quarter and year ended December 31, 2025. Full-year revenue reached $183.6 million, up 13% from 2024, driven by higher product sales in all regions and stronger services in the United States and Canada.
Full-year net income rose to $23.7 million, or $8.65 per diluted share, helped by a $9.2 million income tax benefit from reversing most deferred tax valuation allowances. Adjusted EBITDA increased to $26.7 million with a 15% margin, while free cash flow after distributions to non-controlling interest nearly doubled to $18.9 million.
The company ended 2025 with $36.7 million in cash and $7.6 million of finance-lease-related debt, reflecting a net cash position and expanded financial flexibility. Management highlighted the contribution from the ResMetrics acquisition and expects a challenging 2026 activity environment but aims to outperform markets through share gains and international growth.
NCS Multistage Holdings, Inc. (NCSM) reported that it issued a press release announcing results for the quarter ended September 30, 2025. The press release is furnished as Exhibit 99.1.
The disclosure under Item 2.02 is being furnished, not filed, and is therefore not subject to Section 18 of the Exchange Act. It will not be incorporated by reference into Securities Act filings unless specifically identified.